Skip to main content
Equibles

Birchview Capital, LP

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1618205 BURLINGTON, VT
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$419,641
-$47,971 QoQ
Shares Held
42,952
-48.8% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#50
of 96 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Birchview Capital, LP holds $91,246,272 across 49 Biotechnology names. KPTI ranks #39 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SLDB
Solid Biosciences Inc.
 666,196 $6,655,298
2 NTLA
Intellia Therapeutics, Inc.
 385,900 $6,529,428
3 STOK
Stoke Therapeutics, Inc.
 178,110 $5,827,759
4 NKTR
Nektar Therapeutics
 81,000 $5,654,610
5 CORT
Corcept Therapeutics Inc
 57,200 $4,973,540
6 PRTA
Prothena Corp Public Ltd Co
 449,019 $4,395,896
7 ACAD
Acadia Pharmaceuticals Inc
 171,000 $4,326,300
8 PTGX
Protagonist Therapeutics, Inc
 35,018 $4,292,506

All Filings in KPTI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $419,641 42,952
2026-03-31 $467,612 83,952
2025-09-30 $183,021 27,985
2025-06-30 $120,615 27,985
2025-03-31 $104,663 27,985
2024-12-31 $283,806 419,832
2024-09-30 $389,960 469,832
2024-06-30 $407,814 469,832
2024-03-31 $709,446 469,832
2023-12-31 $406,404 469,832
2023-09-30 $766,254 571,832
2023-06-30 $521,484 291,332
2023-03-31 $1,133,281 291,332
2022-12-31 $990,528 291,332
2022-09-30 $1,470,552 269,332
2022-06-30 $1,214,687 269,332
2022-03-31 $1,984,976 269,332
2021-12-31 $1,581,780 246,000
2021-09-30 $1,431,720 246,000
2021-06-30 $2,373,600 230,000
2021-03-31 $2,419,600 230,000
2020-12-31 $2,910,240 188,000
2020-09-30 $2,452,800 168,000
2020-06-30 $3,181,920 168,000
2020-03-31 $2,843,080 148,000